Active · per the CBE, 16 November 2026

UgenTec

BE0551976421

Rechtspersoon Public limited company 1 establishment

UgenTec is an IT company in Brussel. Public Limited, started on 30 April 2014, 1 establishment.

Regentlaan 54, 1000 Brussel

Active for

12 year, 6 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Negative equity NBB

    More debt than assets in 2 of the last 4 fiscal years.

  • Two loss years in a row NBB

    Negative result in 2024 and 2025.

  • Tight liquidity NBB

    Cash and receivables cover 65 % of short-term debt in 2025; threshold 65 %.

  • Shrinking team NBB

    FTE fell two years in a row, from 55.5 to 2.8.

  • Busy address KBO

    26 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

UgenTec from Brussel, company number BE0551976421, closed financial year 2025 with a result of € -1.7 million after tax. For that financial year UgenTec recorded a gross margin of € 1.1 million and equity of € -2.8 million. Compared with financial year 2024, the result moved from € -4.9 million to € -1.7 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 2, 2026.

What it is worth Caution

€ -2.8 million

▼ € 1.7 million vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -1.7 million

▲ 66 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 301,785

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -10.5 million.

People and assets in 2025

Full-time equivalents

2.8

▼ 24.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 1 million

▼ 73% vs 2024

€ 362,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 5.7 million

▲ 100% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 970

▼ € 745,471 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
2022202320242025Change 2024 → 2025
Revenue € 9,983,898 € 4,678,382 € 2,562,986 -
Gross margin - - € 748,220 € 1,129,312 ▲ 51%
Profit after taxes € 1,512,240 € -4,363,603 € -4,944,023 € -1,702,386 ▲ € 3.2 million
Equity € 5,187,315 € 3,823,712 € -1,120,311 € -2,822,697 ▼ € 1.7 million
Total debts € 2,395,340 € 5,597,840 € 5,819,134 € 6,747,528 ▲ 16%
Cash € 3,382,141 € 3,603,926 € 0 € 301,785
Retained profit € 516,934 € -3,846,669 € -8,790,692 € -10,493,078 ▼ € 1.7 million
Bank debt € 0 € 1,356,023 € 1,230,529 € 0 ▼ 100%
Balance sheet total € 7,582,655 € 9,421,552 € 4,698,823 € 3,924,831 ▼ 16%
Employees (FTE) 54.4 55.5 27.4 2.8 ▼ 24.6

By gross margin, UgenTec ranks 20th of 228 companies with main activity “Ontwerpen van computerprogramma’s” in Brussel that publish figures (fiscal year 2025).

Key figures of UgenTec, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to UgenTec?

What happened at UgenTec in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • James Coffin stepped down as director. NBB
  • Peder Qvigstad stepped down as director. NBB
  • New annual accounts for financial year 2025: loss of € 1.7 million. filed late Source: NBB ↗
  • James Coffin became a director. NBB
  • Emslie Guy stepped down as director. NBB
  • James Littlejohn stepped down as director. NBB
  • Hans Cobben stepped down as director. NBB
  • Emslie Guy became a director. NBB

In short

From € 1.5 million profit in 2022 to € 1.7 million loss in 2025.

Best year ever: 2022, with € 1.5 million profit.

On average € 403,300 of value added per employee in 2025.

Management

The stake of M51 Europe comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

UgenTec

The shares are held by M51 Europe (100%).

Directors

According to the 2025 annual accounts

Hans Cobben

Director

Also active at: DENDRITE, ONTOFORCE

since 2024 · until 2025

Emslie Guy

Director

since 2025 · until 2026

Peder Qvigstad

Director

since 2024 · until 2030

James Littlejohn

Director

since 2024 · until 2025

James Coffin

Director

since 2026 · until 2032

Shareholders

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Regentlaan 54

1000 Brussel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Brussel

Same main activity (Ontwerpen van computerprogramma’s), 294 active companies in Brussel, largest first.

Collibra Belgium

€ 161.7 million revenue · 2025

BNP PARIBAS PARTNERS FOR INNOVATION BELGIUM

€ 73.5 million revenue · 2025

ISABEL

€ 68.5 million revenue · 2025

RECORD CREDITS

€ 64.3 million revenue · 2025

SimCorp Benelux SA/NV

€ 50.3 million revenue · 2025

TELEKOM HELLENIC BUSINESS SOLUTIONS

€ 41.5 million revenue · 2024

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Capital increase

Source: Deed ↗
  • Joachim Jan Anna JACOBS(inschrijver nieuwe aandelen) 1.2%
  • Tom MARTENS(inschrijver nieuwe aandelen) 0.9%
  • Wouter Paul Maria-Louisa UTEN(inschrijver nieuwe aandelen) 0.9%
  • Bart Alfons VERSTRYNGE(inschrijver nieuwe aandelen) 0.1%
  • Devy Shari WIDJAJA(inschrijver nieuwe aandelen) 0.1%
  • Koen JANS(inschrijver nieuwe aandelen) 0.1%
  • Nele OOMS(inschrijver nieuwe aandelen) 0.1%

Capital increase

Source: Deed ↗
  • HERAN HEALTHTECH FUND I(inschrijver door inbreng in natura (schuldvordering)) 7.3%
  • LIMBURGSE RECONVERSIE MAATSCHAPPIJ(inschrijver door inbreng in natura (schuldvordering)) 7.3%
  • GEMMA FRISIUS-FONDS KU LEUVEN(inschrijver door inbreng in natura (schuldvordering)) 1.1%
  • DE MOOR Bart Lodewijk René(inschrijver door inbreng in natura (schuldvordering)) 1.1%
  • UTEN Wouter Paul Maria-Louisa(inschrijver door inbreng in natura (schuldvordering)) 1%
  • VAN VOOREN Steven(inschrijver door inbreng in natura (schuldvordering)) 0.6%
  • VERHOEVEN Steven Dieter(inschrijver door inbreng in natura (schuldvordering)) 0.6%
  • MARECHAL Ivo Antoine Leon(inschrijver door inbreng in natura (schuldvordering)) 0.5%
  • KATHOLIEKE UNIVERSITEIT LEUVEN(inschrijver door inbreng in natura (schuldvordering)) 0.5%
  • REESSINK Michiel(inschrijver door inbreng in natura (schuldvordering)) 0.4%
  • MARTENS Tom(inschrijver door inbreng in natura (schuldvordering)) 0.4%

Capital increase

Source: Deed ↗
  • VERHOEVEN Steven(inschrijver) 3.6%

Incorporation

Source: Deed ↗
  • UTEN Wouter Paul Maria-Louisa(oprichter) 50%
  • MARTENS Tom(oprichter) 50%

Details

Company number
0551.976.421
VAT number
BE 0551.976.421
Registered office
Regentlaan 54, 1000 Brussel
Names & denominations
UgenTec
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
30 April 2014
Peppol
Active · Active since 24 Dec 2025
Activities · NACE

Ontwerpen van computerprogramma’s

Ontwerpen en programmeren van computerprogramma's

Overige diensten op het gebied van informatietechnologie en computer

Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten

Computerconsultancy-activiteiten

Frequently asked questions

What does UgenTec do?
UgenTec is an IT company in Brussel. Public Limited, started on 30 April 2014, 1 establishment.
What is the address of UgenTec?
The registered office of UgenTec is located at Regentlaan 54, 1000 Brussel.
Is UgenTec still active?
Yes. According to the CBE (16 November 2026) UgenTec is active, legal situation “Normale toestand”, started on 30 April 2014.
Is UgenTec registered on Peppol?
Yes, UgenTec is registered on the Peppol network with ID 0208:0551976421.
What is the enterprise number of UgenTec?
The enterprise number of UgenTec is BE0551976421.
When was UgenTec founded?
UgenTec was founded on 30 April 2014.